Uropathologists, for the first time, acknowledge issues with indolent Grade Group 1 tumors, which are leading to ...

Burjeel Holdings has entered a partnership with US-based Paige for deploying AI approved by the Food and Drug Administration ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

The AI Test combines clinical data and digital pathology to calculate prognostic risk scores and determine the risk of distant metastasis or prostate cancer-specific mortality within 10 years. It is ...

Artificial intelligence can help urologists and oncologists make treatment recommendations that are objective and evidence-based.

But he never seemed able to see the same doctor, and when a prostate specific antigen test came back in 2016 showing his ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, has announced a strategic partnership ...

Dr Mohammad Mahmoud shares anticipated updates on evolving local treatments, PSMA-based therapies, and impactful genetic studies.

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score ...

Course Director and Instructor of BIOC 360/460: Advanced Technologies for Cancer Research Course Director and Instructor of PATH 418: Tumor Immunology Faculty Facilitator for IBMS 500: On Being a ...

Opens in a new tab or window A polygenic risk score was able to detect a high proportion of clinically significant prostate cancer. Cancer would not have been detected in 71.8% of patients with ...